Mayo Clinic: Diabetes Mellitus, Type 2 trials

The registry lists 28 Diabetes Mellitus, Type 2 studies with Mayo Clinic as lead sponsor. 2 are open to participants now and 8 have results posted.

Early Phase 1 1Phase 1 3Phase 2 5Phase 3 2Phase 4 3No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 DiabetesRecruitingNCT06976619Phase 2
• A Study of Glycemic Control in Left Ventricular AssistRecruitingNCT05933161
• Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease RiskCompletedNCT05214573Results posted
• Effects of Niacin on Intramyocellular Fatty Acid Trafficking in Upper Body Obesity and Type 2 Diabetes MellitusCompletedNCT03867500Early Phase 1Results posted
• Penile Length Restoration in Men With Diabetes Mellitus, Type IICompletedNCT03756688Not applicableResults posted
• Multicenter Endoscopic Sleeve Gastrectomy (ESG) Trial (MERIT Trial)CompletedNCT03406975Not applicableResults posted
• Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes MellitusCompletedNCT02871882Phase 2Results posted
• The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 DiabetesCompletedNCT02762708Phase 2Results posted
• Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on MetforminCompletedNCT02033876Phase 2Results posted
• The Effect of Welchol on Glucose Metabolism in Type 2 DiabeticsCompletedNCT00951899Phase 4Results posted
• Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid InfusionActive, not recruitingNCT05264727Phase 4
• A Study to Improve Diabetes Management Among Adults Experiencing Severe HypoglycemiaSuspendedNCT04874532Not applicable
• Patient-Derived Stem Cell Therapy for Diabetic Kidney DiseaseTerminatedNCT03840343Phase 1
• PDD in Type 2 Diabetes w/wo Diastolic DysfunctionCompletedNCT03744975Phase 2
• CCK1R Function in Patient LeukocytesCompletedNCT03121755
• The Work of Being a Patient With Diabetes: Data Collection Via a Smartphone ApplicationCompletedNCT02714660
• Epigenetics and the Origin of Muscle Insulin Resistance in HumansCompletedNCT01726491
• Molecular Regulation of Muscle Glucose MetabolismTerminatedNCT01581736Phase 1
• Study to Test Use of a Decision Aid in a Clinical Visit to Help Patients Choose a Diabetes MedicationCompletedNCT01293578Not applicable
• Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin ResistanceCompletedNCT01240252Phase 1
• Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 DiabetesCompletedNCT01021865
• The Effects of LAF237 on Gastric Function in Type 2 DiabetesCompletedNCT00952991Phase 3
• Production of Free Fatty Acids From Blood TriglyceridesCompletedNCT00911482
• Predictive Genetic Risk Assessment TrialCompletedNCT00782366
• Genetic Variation in OCT1 and Response to MetforminWithdrawnNCT00588172Phase 4
• Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes MellitusCompletedNCT00308373Not applicable
• Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes MellitusCompletedNCT00217061Phase 3
• Regional Fatty Acid Metabolism in HumansWithdrawnNCT00068887